Abstract:AIM:Abnormal hyperphosphorylation of tau plays a critical role in the pathogenesis of Alzheimer's disease(AD),and tau protein was hyperphosphorylated in type 2 diabetes. The present study was designed to explore the phosphorylation level of tau in hippocampus of type 2 diabetes rats which interrupted by very low density lipoprotein receptor(VLDLR)gene transfection. METHODS:Wistar male rats were randomized into 3 groups. The control group(CTL)was fed with normal food. The T2DM group and T2DM mediated VLDLR gene group were on high sugar,high fat and high protein diet for 3 months. The plasma insulin level was measured by RIA method,and the plasma glucose was determined by glucose-oxidase method. Total tau level,the phosphorylation level of tau at individual phosphorylation sites and the level of VLDLR were analyzed by Western blotting. The activity of glycogen synthase kinase 3β,a key component of insulin signal transduction pathway and a known tau kinase,in the hippocampus of rats was determined by using [γ-32P]-ATP and the specific peptide substrate. RESULTS:No significant difference of total tau level in hippocampus between T2DM group and T2DM mediated VLDLR gene group was observed. Tau protein in T2DM group was found to be more hyperphosphorylated at several AD-related phosphorylation sites(Ser214,Thr217,Ser396,Ser422 and Ser199/202)than that in CTL,while the immunoreaction at tau-1 site is weaker than that in CTL. VLDLR gene therapy reduced hyperphosphorylation sites of Thr217,Ser396,Ser422 and Ser199/202 of tau to almost the control level,but did not change the phosphorylation of Ser214 or Ser422 on tau. The expression of Ser214 was also observed by immunohistochemical assay. The phosphorylated tau modestly increased in hippocampus in T2DM group compared to CTL,but VLDLR gene treatment did not change the phosphorylation level. The phosphorylation of GSK-3β was decreased dramatically in the hippocampus in T2DM rats,and this phosphorylation was significantly increased after VLDLR gene treatment. CONCLUSION:These findings suggest that Raav mediated VLDLR gene treatment partially reverses tau hyperphosphorylation at several sites in T2DM rat hippocampus,which may mediate by inhibition of GSK-3β activity.

Disturbance of Gsk-3 and Pp-2a Induced Tau Hyperphosphorylation in Diabetic Rat Brain

Glycogen synthase kinase-3 regulates production of amyloid-β peptides and tau phosphorylation in diabetic rat brain.

Effects Of Streptozotocin-Induced Diabetes On Tau Phosphorylation In The Rat Brain

Expression Changes of Growth-Associated Protein-43 (Gap-43) and Mitogen-Activated Protein Kinase Phosphatase-1 (Mkp-1) and in Hippocampus of Streptozotocin-Induced Diabetic Cognitive Impairment Rats

Specific Changes of Somatostatin Mrna Expression in the Frontal Cortex and Hippocampus of Diabetic Rats

[Mechanism of Tau Hyperphosphorylation in Brain Cortex of Diabetic Rats and Effect of LiCl].

[The Investigation of Syn and NPY Expression in Brain Tissues of Diabetic Model Rat Induced by Streptozotocin].

The Disturbance of Hippocampal Camkii/Pka/Pkc Phosphorylation in Early Experimental Diabetes Mellitus

Inhibiting PI3K leads to glucose metabolism disturbance in default mode network

[Alteration of Beta-Amyloid and Glutamate Transporter in the Brain of Diabetes Rats and the Underlying Mechanism].

Hypoglycemia induces tau hyperphosphorylation

Roles of Glycogen Synthase Kinase 3 in Alzheimer’s Disease

Raav-Mediated VLDLR Gene Transfection Reduces Tau Hyperphosphorylation in Hippocampus of Type 2 Diabetic Rats

Chronic hyperglycemia induces tau hyperphosphorylation by downregulating OGT-involved O-GlcNAcylation in vivo and in vitro.

Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory.

DISC1 inhibits GSK3β activity to prevent tau hyperphosphorylation under diabetic encephalopathy

Molecular alteration of the proteasome contributes to AD-like pathology in the brain of HFD-STZ diabetic rats

High Glucose Induces Tau Hyperphosphorylation in Hippocampal Neurons Via Inhibition of ALKBH5-mediated Dgkh M6a Demethylation: a Potential Mechanism for Diabetic Cognitive Dysfunction

Hyperphosphorylation of Tau Protein in Hippocampus of Central Insulin-Resistant Rats is Associated with Cognitive Impairment

The possible mechanism underlying tau hyperphosphorylation in rats subjected to chronic brain ischemia

The possible mechanism of insulin reducing amyloid beta peptide in the brain cortex of diabetic rats